BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

989 related articles for article (PubMed ID: 35116848)

  • 1. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic analysis identifies three-lncRNA signature as a potentially prognostic biomarker for lung squamous cell carcinoma using bioinformatics strategy.
    Hu J; Xu L; Shou T; Chen Q
    Transl Lung Cancer Res; 2019 Oct; 8(5):614-635. PubMed ID: 31737498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma.
    Wu X; Sui Z; Zhang H; Wang Y; Yu Z
    Front Oncol; 2020; 10():554759. PubMed ID: 33042838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma.
    Cui Y; Cui Y; Gu R; Liu Y; Wang X; Bi L; Zhang S; Fan W; Tian F; Zhan Y; Zhang N; Xing Y; Cai L
    J Oncol; 2021; 2021():2659550. PubMed ID: 34987577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Seven-Long Non-coding RNA Signature Improves Prognosis Prediction of Lung Adenocarcinoma: An Integrated Competing Endogenous RNA Network Analysis.
    Li R; Han K; Xu D; Chen X; Lan S; Liao Y; Sun S; Rao S
    Front Genet; 2020; 11():625977. PubMed ID: 33584817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Dong R; Liu J; Sun W; Ping W
    Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks.
    Wu X; Liu J; Zhu C; Ma M; Chen X; Liu Y; Xia N; Dong Q
    Med Sci Monit; 2020 Dec; 26():e927725. PubMed ID: 33328429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma.
    Jing Z; Guo S; Zhang P; Liang Z
    Technol Cancer Res Treat; 2020; 19():1533033820985787. PubMed ID: 33371795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of a long noncoding RNA-associated competing endogenous RNA network in colorectal cancer.
    Fan Q; Liu B
    Onco Targets Ther; 2018; 11():2453-2466. PubMed ID: 29760555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
    Liu N; Liu Z; Liu X; Chen H
    Front Oncol; 2019; 9():935. PubMed ID: 31649871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a ceRNA network and a genomic-clinicopathologic nomogram to predict survival for HBV-related HCC.
    Huang K; Lu Z; Li L; Peng G; Zhou W; Ye Q
    Hum Cell; 2021 Nov; 34(6):1830-1842. PubMed ID: 34487338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification Invasion-Related Long Non-Coding RNAs in Lung Adenocarcinoma and Analysis of Competitive Endogenous RNA Regulatory Networks.
    Mao Y; Cai F; Jiang T; Zhu X
    Int J Gen Med; 2023; 16():1817-1831. PubMed ID: 37213476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis.
    Pan YQ; Xiao Y; Long T; Liu C; Gao WH; Sun YY; Liu C; Shi YJ; Li S; Shao AZ
    Front Oncol; 2022; 12():1022097. PubMed ID: 36300102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
    Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
    Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
    Cao D; Wang Y; Li D; Wang L
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of differentially expressed Her-2 related lncRNA-mRNA-miRNA ceRNA network in Her-2 positive breast cancer.
    Jia X; Meng W; Zhang L; Jia Y; Shi Y; Tong Z
    Transl Cancer Res; 2020 Apr; 9(4):2527-2533. PubMed ID: 35117612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.
    Li Y; Yu X; Zhang Y; Wang X; Zhao L; Liu D; Zhao G; Gao X; Fu J; Zang A; Jia Y
    Biomed Eng Online; 2021 Nov; 20(1):117. PubMed ID: 34819106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.